Eli Lilly And Co
5 products tracked · names used in filings: Eli Lilly And Co, Eli Lilly and Company Limited, Eli Lilly and Company (Ireland) Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 23 Sep 2026🇺🇸 FDA approval
FDA approves biosimilar Onswik (insulin efsitora alfa-gobe)
Eli Lilly And Co; BLA761408; Biosimilar; injectable · source
Wed 01 Apr 2026🇺🇸 FDA approval
FDA approves Foundayo (orforglipron calcium), a new medicine
Eli Lilly And Co; NDA220934; New molecular entity; tablet · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Onswik insulin efsitora alfa-gobe | Approved | 2026-09-23 |
| 🇺🇸 | Foundayo orforglipron calcium | Approved | 2026-04-01 |
| 🇺🇸 | Inluriyo imlunestrant tosylate | Approved | 2025-09-25 |
| 🇪🇺 | Taltz ixekizumab | Authorised | 2016-04-25 |
| 🇪🇺 | Liprolog insulin lispro | Withdrawn | 1997-05-07 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.